1. Current use of primary cultures of human hepatocytes for investigating drug metabolising enzymes Drug metabolizing enzymes have been classified as either phase I (oxygenases , reductases, hydrolases) or phase II (conjugation enzymes) . These enzymes are expressed primarily in the liver but also in the intestine, kidney, lung, skin, etc. CYPs from families CYP1 , CYP2 and CYP3 play a prominent part in drug metabolism. The level and activity of CYPs may be affected by a number of factors including genetic defects (polymorphisms) , drugs acting as either inducers or inhibitors, as well as by physiopathological stimulii such as oxygen concentration changes , cytokines, cell-cell contacts and growth factors. These various possibilities of modulation account for the wide interindividual variability exhibited by humans in their capacity to metabolise drugs . For the last ten years a number of laboratories have been involved in investigating drug metabolism and side effects in human hepatocytes cultures (Maurel Adv Drug Del Rev 22 , 105, 1996; Guillouzo in "In Vitro Toxicity Testing. Application to Safety Evaluation" , Marcel Dekker, New York, p 45, 1992; Rogiers et al. Toxicol In Vitro 9, 685, 1995; Guguen-Guillouzo et al . Exp Cell Res 143, 47, 1983; Schuetz et al. J Cell Physiol 134, 309, 1988; Dunn et al . Biotechnol Prog 7, 237, 1991; Koebe et al . Xenobiotica 24, 95, 1994; Isom et al. Proc Natl Acad Sci 82 , 3252, 1985; Li et al. J Pharm Exp Ther 274, 673, 1995) .
Since the metabolism of a drug may involve several enzymes of both phase I and II , some of which are microsomal other cytosolic, only differentiated hepatocytes are convenient to predict the metabolic pathway. A good correlation is generally reported between the metabolite profile in man in vivo and in hepatocyte cultures (Sandker et al . Xenobiotica 24, 143, 1994; Chenery et al . Drug Metab Dispos 15, 312, 1987; Le Bigot et al. Life Sci 40 , 883, 1987; Pichard et al. Drug Metab Dispos 23, 1253 , 1995 . The screening of inducers of CYPs and other drug metabolizing enzymes is another point which requires the use of human hepatocyte in culture . Indeed it has been demonstrated previously that data obtained with animal models (rat , mouse) are frequently not relevant to the human situation. For example rifampicin and omeprazole, two inducers of CYP3A and CYPIA, respectively, in man are not inducers in rat or mouse (Wrighton et al. Mol Pharmacol 28, 312, 1985; Dzeletovic et al. J Biol Chem 272, 12705, 1997) Another interesting aspect of these cultures is that they offer a unique means for investigating the influence of physiopathological stimuli on drug metabolism and related processes. For example we and others investigated the effect of various cytokines on CYP expression (Muntane-Relat et al . Hepatology 22, 1143 Hepatology 22, , 1995 Abdel-Razzak et al. Mol Pharmacol 44, 707, 1993; Williams et al . Biochem Biophys Res Commun 178, 1049 , 1991 . It was found that interleukine-1 (Il-1) , 11-6 and tumor necrosis factor alpha down regulate the constitutive and inducible expression of CYP genes . This is in agreement with the observation that the capacity to metabolize drugs is reduced during infections and other pathological disorders involving inflammation. Other investigations included the study of the influence of hepatotrophic factors such as EGF, TGFa and HGF to tentatively mimic the situation of liver regeneration (Greuet et al. Hepatology 25, 1166 , 1997 , and the influence of hypoxia to simulate the abnormalities which occur in critically ill patients (Park et al . Anaesthesia 49, 188, 1994) 2. Long-term culture and in vitro differentiation of human hepatocytes Recent investigations aimed at evaluating the best conditions for preserving the differentiated phenotype of cultured hepatocytes have emphasized the role of several parameters including the cell substratum (collagen, matrigel, collagen sandwich), the composition of the culture medium (use of hormones, vitamines and growth factors) and cell density, as reviewed (Maurel , Advanced Drug Delivery Rev 22, 105, 1996) . This last point is critical. We reported that human hepatocytes in culture rapidly lose their differentiated phenotype (including CYP inducibility) when cultured at low cell density, that is, under conditons where most of cell-cell contacts are lost and where cells become committed for entering the cell division cycle (Greuet et al. Hepatology 25 , 1166 , 1997 . preparation is a real problem for the future. One possibility to overcome this difficulty is to develop long-term culture systems that would allow a large number of experiments to be carried out with the same hepatocyte preparation. Several systems for long-term culture of mammalian hepatocytes have been described in the last ten years. These include, co-culture of hepatocytes with a rat liver epithelial cell line (Guguen-Guillouzo et al. Exp Cell Res 143, 47, 1983) , the use of extracellular matrix components including Matrigel and sandwich or gel of collagen (Schuetz et al. J Cell Physiol 134, 309, 1988; Dunn et al. Biotechnol Prog 7, 237, 1991; Koebe et al. Xenobiotica 24, 95, 1994) , and the use of a specific additive such as dimethylsulfoxide (Isom et al. Proc Natl Acad Sci 82, 3252, 1985) . On the other hand, the capacity of cultured human hepatocytes to remain differentiated in vitro is still a matter of debate. This question is relevant for utilisation of such cultures to study drug metabolism and other aspects of liver physiology.
In our laboratory, we have established a long-term culture system for adult normal human hepatocytes (Ferrini et al. Chemico-Biol Int 107, 31, 1997) which is based on a system previously used for baboon hepatocytes (Lanford et al. In vitro Cell Dev Biol 25, 174, 1989) . This system has the advantage of not requiring the use of additive cells or a matrix component preparation and is therefore as easy to use as the conventional culture systems. In this system, human hepatocytes plated at confluence on collagen-coated dishes and cultured in a serum-free medium supplemented with hormones and growth factors can be maintained in culture for at least 78 days. To determine whether these hepatocytes retain differentiated phenotype we examined several specific properties including secretion of plasma proteins including the secretion of albumin , a-1 antitrypsin, plasminogen, fibrinogen, lipoproteins ApoA1 and ApoB 100, as well as expression and inducibility of the CYP1, CYP2 and CYP3 gene families in response to their prototypical inducers . We also monitored the metabolism of different CYP1A2-, CYP2C9-, CYP3A4-specific substrates by HPLC analysis of the extracellular medium (Ferrini et al. Chemico-Biol Int 107, 31 , 1997) . These data demonstrated that hepatocytes cultured for at least 35 days have indeed undergone the process of differentiation which was further confirmed by increased expression and function of two members of the C/EBP family, C/EBPa and 13. In addition, we have studied the expression of several cell The HCV replication cycle is poorly understood because its study has been hampered by the low titer of infectious virus present in serum or liver tissue, and by the lack of a culture system capable of supporting efficient virus replication. Although evidence of infection of non-hepatic cells has been suggested (Lerat et al. J Clin Invest 97, 845, 1996) , HCV is a hepatotrophic virus with presumably a preference for infection of differentiated human hepatocytes (Laskus et al. J Gen Virol 78, 2747 , 1997 . Despite recent progress made in this direction with the use of human mononuclear cells (Cribier et al. J Gen Virol 76, 2485 , 1995 or cellular cell lines of various origins (Nakajima et al. J Gen Virol 70, 3325, 1996; Tagawa et al. J Gastroenterol Hepatol 10, 523, 1995; Kato et al. Japan J Cancer Res 87, 787, 1996; Seipp et al. J Gen Virol 78, 2467 , 1997 , efficient long-term in vitro replication has not been demonstrated. Primary cultures of chimpanzee and human fetal hepatocytes have been shown to be susceptible to HCV infection (Lanford et al. Virology 69, 8079, 1995; lacovacci et al. Hepatology 26, 1328 lacovacci et al. Hepatology 26, , 1997 , and primary hepatocytes isolated from patients with chronic HCV infection were used for the production of HCV particles in vitro (Ito et al . J Gen Virol 77, 1043 , 1996 . However, efforts in developing a cell culture system susceptible to infection and permissive to replication of HCV remain a priority.
In our laboratory, we have used our system of long-term culture of differentiated adult normal human hepatocytes to investigate the in vitro infection and replication cycle of HCV (Fournier et al. Hepatology 26, 248A, 1997; Fournier et al. J Gen Virol in press, 1998) . Hepatocytes were prepared from liver tissue resected from donors tested negative for HCV , and inoculation was performed 3 days after plating with 33 HCV serum samples of different viral load and genotype (including genotypes HCV la, lb, 2a, 2a/2c and 3a) . The presence of intracellular HCV RNA, detected by a strand-specific rTth RT-PCR assay , was used as evidence of infection. A kinetic analysis of HCV replication revealed that intracellular negative strand RNA appeared at day 1 post-infection with a maximum level at days 3 and 5, followed by a decrease until day 14. At day 5, we evaluated that the copy level of viral RNA was amplified 25 fold in infected cells . Analysis of cellular HCV RNA in response to different serum samples were reproducible from one hepatocyte culture to another suggesting that there is no inter-individual variability in the susceptibility of hepatocytes to HCV infection. Among the 33 serum samples tested , only 10 (9 of genotype la or lb, and 1 of genotype 2) were found to produce intracellular negative-strand HCV RNA signals .
These inocula all exhibited high HCV titer (> 22 Meq/ml) . However, some sera of high titer did not lead to the detection of intracellular negative-strand HCV RNA after inoculation . It appears therefore that a high titer of HCV in the inoculum is necessary but not sufficient for in vitro infection of human hepatocytes in primary culture. These preliminary results obtained with a highly sensitive and specific method demonstrate that differentiated adult human hepatocytes in primary culture retain their sensitivity to HCV infection and their permissivity to HCV RNA replication . This work provides a new and reliable in vitro model for investigating the initial steps of the replication cycle of HCV and for the evaluation of antiviral molecules .
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